Latest Neurizon Therapeutics (ASX:NUZ) News
Page 1
Page 1 of 6
Neurizon opens $2 million SPP with free options ahead of ALS trial results
16 Nov 2026
Healthcare Wrap - Week 46 (9 Nov -> 13 Nov) 2026
14 Nov 2026
Neurizon moves NUZ-001 ALS trial into active treatment extension
13 Nov 2026
Market Wrap - Week 45 (2 Nov -> 6 Nov) 2026
7 Nov 2026
Healthcare Wrap - Week 45 (2 Nov -> 6 Nov) 2026
7 Nov 2026
Neurizon clears convertible notes as $6.3m funding plan targets ALS trial readout
5 Nov 2026
Neurizon replaces convertible funding with A$6.3m equity raise ahead of ALS results
2 Nov 2026
Market Wrap - Week 41 (5 Oct -> 9 Oct) 2026
10 Oct 2026
Healthcare Wrap - Week 41 (5 Oct -> 9 Oct) 2026
10 Oct 2026
FDA Opens Potential Single-Trial Approval Pathway for Neurizon’s NUZ-001
6 Oct 2026
Market Wrap - Week 37 (7 Sept -> 11 Sept) 2026
12 Sept 2026
Healthcare Wrap - Week 37 (7 Sept -> 11 Sept) 2026
12 Sept 2026